Media Center

On June 11, 2025, Wandercraft a pioneering French robotics company announced the successful close of its Series D funding round. raising $75 million in equity and debt financing . This capital injection comes at a pivotal moment for the company, as it prepares to scale its robotics solutions across healthcare, personal mobility, and industrial sectors. Backed by a consortium of strategic and institutional investors including Renault Group, the PSIM fund (managed by Bpifrance

We are proud to highlight a major regulatory and strategic milestone achieved by Hexoskin , one of ballas invest’s portfolio companies.The Hexoskin Medical System (HMS)  has officially received FDA 510(k) clearance  for long-term ECG and respiratory monitoring a key step toward large-scale deployment of continuous remote care solutions in the United States. This clearance marks an important validation of Hexoskin’s technology and reinforces its position as a leading player in

In a world where healthcare is becoming more fragmented and reactive, Heloa—formerly known as Malo—is quietly rewriting the rules. This French HealthTech startup is on a mission to bring coherence, care, and clarity to one of the most critical, yet underserved, segments of healthcare: early childhood development. From pregnancy to a child’s seventh birthday, Heloa accompanies families with an AI-powered, data-rich platform that anticipates and detects health and developmental

At ballas invest, we back bold companies reshaping the future of healthcare, and Wandercraft exemplifies that mission. This Paris-based...

At ballas invest, we firmly believe in the transformative power of technology to reshape healthcare across Europe. We are thrilled to...